Toothpaste and toothbrush giant Colgate-Palmolive hit a full-year revenue ... and make sure their analysis is clear and in no way misleading or deceptive. To further protect the integrity of ...
Jeremy Bowman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Colgate-Palmolive. The Motley Fool has a disclosure policy.
Colgate-Palmolive reported stable earnings for Q4 2024, beating EPS estimates but just missing revenue expectations.
In this article, we are going to take a look at where Colgate-Palmolive Company (NYSE:CL) stands against other best dividend stocks to buy and hold. In recent years, many investors have shifted ...
Access our full analysis report here, it’s free. Colgate-Palmolive’s shares are not very volatile and have had no moves greater than 5% over the last year. In that context, today’s move ...
Shares of Colgate-Palmolive (NYSE:CL) are trading defensively ahead of Friday’s opening bell as mixed fourth quarter results, including FY24 milestone revenue of $20B, were overshadowed by ...
Colgate-Palmolive Co. shares are down 4.9% Friday despite the toothpaste and toothbrush giant reporting better-than-expected fourth-quarter profit and hitting a full-year revenue milestone.
Shares of Colgate-Palmolive (NYSE: CL) pulled back today after the household products giant missed the mark on the top line in its fourth-quarter earnings report and gave a weak outlook.
Consumer goods manufacturer Colgate-Palmolive (NYSE:CL) reported mixed fourth-quarter and full-year 2024 earnings on Friday, Jan. 31. Adjusted earnings per share (EPS) for Q4 rose to $0.91 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results